Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1888-1894

  Chan, Annie On On ^b   Chu, Kent Man ^a   Yuen, Siu Tsan ^b   Leung, Suet Yi ^b   Lam, Shiu Kum ^b   Wong, John ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLIC ACID; DEOXYCHOLIC ACID; LIPID; LITHOCHOLIC ACID; PHOSPHOLIPID; PLACEBO; TETRAHYDROLIPSTATIN; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; FEMALE; GALLBLADDER MOTILITY; HEPATOBILIARY SYSTEM; HUMAN; LIPID BILE LEVEL; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; BILE; BILE ACIDS AND SALTS; CHOLESTEROL; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENZYME INHIBITORS; FEMALE; GALLBLADDER; HUMANS; LACTONES; LIPASE; LIPIDS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 0034976310     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02346-2     Document Type: Article

References (29)

1. A population study of the prevalence of gallstone disease: The Sirmione study
2. Risk of symptomatic gallstones in women with severe obesity
3. Prevalence rates of gallstone disease in Italy
4. Association of ethnicity and body mass index (BMI) with gallstone disease in the United States
5. Prevalence and treatment of gallstones after gastric bypass surgery for morbid obesity
6. Gallstone formation during weight-reduction dieting
7. Gallstone formation after rapid weight loss: A prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity
8. Cholelithiasis in patients treated with a very-low-calorie diet
9. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss
10. Contribution of obesity and weight loss to gallstone disease
11. Medically safe rate of weight loss for the treatment of obesity: A guideline based on risk of gallstone formation
12. Effects of obesity and caloric intake on biliary lipid metabolism in man
13. Biliary lipid metabolism in obesity: Effects of bile acid feeding before and during weight reduction
14. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients: Effects of biliary lipid metabolism during weight maintenance and weight reduction
15. Mechanisms of gallstone formation in women: Effects of extrogenous estrogen (premarin) and dietary cholesterol on hepatic lipid metabolism
16. Gallbladder kinetics in obese patients; effect of a regular meal and low-calorie meal
17. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss
18. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers
19. Mode of action of orlistat
20. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
21. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial
22. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction
23. Phosphorus assay in column chromatography
24. A simple calculation of the lithogenic index of bile: Expressing biliary lipid composition on rectangular coordinates
25. Gallbladder emptying stimuli in obese and normal-weight subjects
26. Ultrasonographic study of gallbladder emptying in obese patients
27. Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal and muscular normal) people
28. Obesity and risk of gallstone development on a 1200 kcal/d (5025 Kj/d) regular food diet
29. Obesity and gallbladder disease